Modulation of platelet [3H] iloprost binding by cholesterol, dibucaine and pentoxifylline.
Jaschonek
K
K
Medizinische Klinik der Universität Tübingen, FRG.
Funck
M
M
Muller
C P
CP
Schmidt
H
H
D001665:Binding Sites; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism*; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D002788:Cholesterol Esters / Q000494:pharmacology; D003992:Dibucaine / Q000494:pharmacology; D011464:Epoprostenol / Q000097:blood*; D006801:Humans; D016285:Iloprost; D066298:In Vitro Techniques; D007700:Kinetics; D010431:Pentoxifylline / Q000494:pharmacology; D011982:Receptors, Prostaglandin / Q000187:drug effects / Q000378:metabolism
D002788:Cholesterol Esters; D011982:Receptors, Prostaglandin; D011464:Epoprostenol; D016285:Iloprost; D003992:Dibucaine; D010431:Pentoxifylline; C013440:cholesteryl succinate